Healthcare Switch 2.5%
SELL -Resmed (RMD)1.5%
&
Telix Pharmaceutical (TLX) 1%
ADD - DRUG ETF 2.5%
*** GENERAL ADVICE ONLY ***
Description
Sector: Healthcare
With the US market at record highs despite central banks clearly informing the market that interest rates will stay higher for longer, we see the overall market looking overvalued.
The recent run in RMD and TLX has been impressive and we are over 20% in the money on both and taking profits to add to our existing holding, DRUG ETF is appropriate as the diversity provides safety
Resmed (RMD) current allocation 3% REDUCE TO 1.5% ALLOCATION
Profit +18%
Telix Pharma (TLX) current allocation 2% REDUCE TO 1% ALLOCATION
Profit 24%
Global Healthcare ETF (DRUG) current allocation 2.5% ADD TO INCREASE TO 5%
Metrics
Date: 29/1/2024
Market Cap: $767.45M
PE: 25.91
Yield: 0.33%
Trade
Allocation: 2% Entry: $15.5 Target: $24 Trim: $19 Stop: $12.5
Disclaimer: The recommendation given is general advice only. It does not take into account your personal objectives, financial situation, or specific needs. This information should not be your sole resource when making such decisions. We strongly recommend you to seek the advice of financial, taxation, and legal professionals before finalising any investment decisions.